GALANIN RECEPTOR LIGANDS AS POTENTIAL THERAPEUTIC AGENTS IN DEPRESSION AND NEURODEGENERATION

被引：0
|
作者：
BARTFAI, T
LANGEL, U
机构：
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 1995年 / 30卷
关键词：
GALANIN; RECEPTOR; ANTAGONIST; COGNITION; ANTIDEPRESSANT; NEUROPEPTIDE; SUBTYPES; ACETYLCHOLINE; ALZHEIMERS DISEASE;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：S163 / S174
页数：12
相关论文
共 50 条
  • [1] Galanin receptor ligands
    Langel, Ulo
    SPRINGERPLUS, 2015, 4 : 1 - 32
  • [2] Galanin receptor ligands
    Lu, XY
    Lundström, L
    Langel, U
    Bartfai, T
    NEUROPEPTIDES, 2005, 39 (03) : 143 - 146
  • [3] Novel systemically active galanin receptor 2 ligands in depression-like behavior
    Saar, Indrek
    Lahe, Jaanus
    Langel, Kent
    Runesson, Johan
    Webling, Kristin
    Jaerv, Jaak
    Rytkonen, Jussi
    Narvanen, Ale
    Bartfai, Tamas
    Kurrikoff, Kaido
    Langel, Ulo
    JOURNAL OF NEUROCHEMISTRY, 2013, 127 (01) : 114 - 123
  • [4] Galanin receptor subtypes as potential therapeutic targets
    Wang, S
    Parker, EM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (10) : 1225 - 1235
  • [5] Novel galanin receptor subtype specific ligands in feeding regulation
    Saar, Indrek
    Runesson, Johan
    McNamara, Ilan
    Jaerv, Jaak
    Robinson, John K.
    Langel, Ulo
    NEUROCHEMISTRY INTERNATIONAL, 2011, 58 (06) : 714 - 720
  • [6] Novel galanin receptor ligands
    Pooga, M
    Juréus, A
    Rezaei, K
    Hasanvan, H
    Saar, K
    Kask, K
    Kjellén, P
    Land, T
    Halonen, J
    Maeorg, U
    Uri, A
    Solyom, S
    Bartfai, T
    Langel, U
    JOURNAL OF PEPTIDE RESEARCH, 1998, 51 (01): : 65 - 74
  • [7] Therapeutic potential of neuropeptide Y (NPY) receptor ligands
    Brothers, Shaun P.
    Wahlestedt, Claes
    EMBO MOLECULAR MEDICINE, 2010, 2 (11) : 429 - 439
  • [8] Galanin, galanin receptor subtypes and depression-like behaviour
    Kuteeva, E.
    Hokfelt, T.
    Wardi, T.
    Ogren, S. O.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2008, 65 (12) : 1854 - 1863
  • [9] Histamine H4 receptor ligands and their potential therapeutic applications
    Kiss, Robert
    Keserue, Gyoergy M.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (02) : 119 - 135
  • [10] Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19
    Zarei, Malek
    Sahebi Vaighan, Navideh
    Ziai, Seyed Ali
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2021, 43 (06) : 633 - 643
12345